ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,386.58
-0.45%
Dow Jones
39,806.77
0.00%
Gold vs US Dollar
2,427.185
0.03%
Brent Oil
82.275
-1.50%
Bitcoin
71,315.48
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) News

BioCardia (BCDA)

BioCardia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCDA
DateTimeSourceHeadlineSymbolCompany
14/05/202421:02GlobeNewswire Inc.BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
01/05/202412:00GlobeNewswire Inc.BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesNASDAQ:BCDABioCardia Inc
25/04/202414:00GlobeNewswire Inc.BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortNASDAQ:BCDABioCardia Inc
27/03/202420:00GlobeNewswire Inc.BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
20/03/202411:00GlobeNewswire Inc.BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024NASDAQ:BCDABioCardia Inc
13/03/202411:00GlobeNewswire Inc.BioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipNASDAQ:BCDABioCardia Inc
12/03/202411:00GlobeNewswire Inc.BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyNASDAQ:BCDABioCardia Inc
04/03/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
04/03/202413:00GlobeNewswire Inc.BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart FailureNASDAQ:BCDABioCardia Inc
27/02/202421:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
15/02/202412:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCDABioCardia Inc
14/02/202422:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
14/02/202421:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCDABioCardia Inc
09/02/202414:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202412:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202412:00GlobeNewswire Inc.BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDANASDAQ:BCDABioCardia Inc
06/02/202421:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
02/02/202419:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
31/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
31/01/202412:00GlobeNewswire Inc.BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics ConferenceNASDAQ:BCDABioCardia Inc
03/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
03/01/202412:00GlobeNewswire Inc.BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for ShareholdersNASDAQ:BCDABioCardia Inc
19/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
19/12/202312:00GlobeNewswire Inc.BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection FractionNASDAQ:BCDABioCardia Inc
18/12/202312:16GlobeNewswire Inc.BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation MinutesNASDAQ:BCDABioCardia Inc
18/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202311:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202311:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCDABioCardia Inc
06/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCDABioCardia Inc
05/12/202321:11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BCDABioCardia Inc
 Showing the most relevant articles for your search:NASDAQ:BCDA

Your Recent History

LSE
POS
Plexus
LSE
VAL
Valirx
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
PHE
Powerhouse Energy
LSE
SYME
Supply@me Capital
LSE
GKP
Gulf Keystone Petroleum
LSE
SOLG
Solgold
LSE
CHLL
Chill Brands
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
LSE
AAZ
Anglo Asian Mining
LSE
SCE
Surface Transforms
LSE
GOLD
LSE
KEFI
Kefi Gold And Copper
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved